Intra-Cellular Therapies
ITCI
$72.00
Share price
-6.12%
Change (1 day)
15.40%
Change (1 year)
Categories
Number of shares outstanding for Intra-Cellular Therapies (ITCI)
Number of shares outstanding as of April 2024 : 96,143,083
According to Intra-Cellular Therapies's latest financial reports and stock price the company's current number of shares outstanding is 96,143,083. At the end of 2023 the company had 96,143,083 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Intra-Cellular Therapies from 2013 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 96.14 M | 1.47% |
| 2022 | 94.75 M | 16.29% |
| 2021 | 81.47 M | 1.47% |
| 2020 | 80.29 M | 45.26% |
| 2019 | 55.27 M | 0.96% |
| 2018 | 54.75 M | 0.63% |
| 2017 | 54.4 M | 25.73% |
| 2016 | 43.27 M | 0.51% |
| 2015 | 43.05 M | 46.28% |
| 2014 | 29.43 M | 32.82% |
| 2013 | 22.15 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Xencor XNCR | 60,621,534 | -36.95% | 🇺🇸 USA |
 MediciNova MNOV | 49,046,246 | -48.99% | 🇺🇸 USA |
 Curis CRIS | 5,720,789 | -94.05% | 🇺🇸 USA |